Inventor · disambiguated record
Herman Waldmann
Also filed as: WALDMANN HERMAN
32 granted patents·16 pending applications·1,818 citations·filing 1988–2023
98Inventor score
Top patents by PatentIndex Score
48 records- 0196US7993641B2Methods of treatment using anti-CD3 antibodiesBTG INT LTD·Filed 2006·Granted Aug 9, 2011·47 cites·14 claims
- 0296US5585097AHumanized anti-CD3 specific antibodiesBRITISH TECH GROUP·Filed 1992·Granted Dec 17, 1996·273 cites·4 claims
- 0395US6706265B1Humanized anti-CD3 specific antibodiesBTG INT LTD·Filed 1995·Granted Mar 16, 2004·159 cites·20 claims
- 0494US6120766ACDW52-specific antibody for treatment of multiple sclerosisFiled 1992·Granted Sep 19, 2000·216 cites·6 claims
- 0594US5997867AMethod of using humanized antibody against CD18Filed 1995·Granted Dec 7, 1999·254 cites·18 claims
- 0694US5502167ACDR grafted humanised chimeric T-cell antibodiesFiled 1992·Granted Mar 26, 1996·212 cites·6 claims
- 0793US7247480B2Method for producing dendritic cellsISIS INNOVATION·Filed 2001·Granted Jul 24, 2007·37 cites·38 claims
- 0892US7994289B2Humanized anti-CD3 antibodiesBTG INT LTD·Filed 2003·Granted Aug 9, 2011·44 cites·14 claims
- 0992US5968509AAntibodies with binding affinity for the CD3 antigenBTG INT LTD·Filed 1994·Granted Oct 19, 1999·134 cites·7 claims
- 1091US7465790B2Therapeutic antibodiesISIS INNOVATION INC·Filed 2001·Granted Dec 16, 2008·67 cites·4 claims
- 1188US5985279AHumanized antibody against CD18Filed 1992·Granted Nov 16, 1999·70 cites·28 claims
- 1288US5690933AMonoclonal antibodies for inducing toleranceGLAXO WELLCOME INC·Filed 1994·Granted Nov 25, 1997·62 cites·4 claims
- 1387US5846534AAntibodies to the antigen campath-1BRITISH TECH GROUP·Filed 1994·Granted Dec 8, 1998·64 cites·18 claims
- 1486US6569430B1Antibodies to the antigen Campath-1BTG INT LTD·Filed 1995·Granted May 27, 2003·47 cites·18 claims
- 1584US8440190B2Antibody variantsWALDMANN HERMAN·Filed 2005·Granted May 14, 2013·4 cites·13 claims
- 1684US6056956ANon-depleting anti-CD4 monoclonal antibodies and tolerance inductionGLAXO WELLCOME INC·Filed 1995·Granted May 2, 2000·56 cites·9 claims
- 1783US7781213B2Method for producing dendritic cellsISIS INNOVATION·Filed 2008·Granted Aug 24, 2010·3 cites·18 claims
- 1883US7473556B2Method for producing dendritic cellsISIS INNOVATION·Filed 2007·Granted Jan 6, 2009·3 cites·18 claims
- 1982US8232100B2Method for producing dendritic cellsWALDMANN HERMAN·Filed 2010·Granted Jul 31, 2012·3 cites·8 claims
- 2080US8921104B2Method for producing dendritic cellsWALDMANN HERMAN·Filed 2012·Granted Dec 30, 2014·2 cites·19 claims
- 2174US6689869B2Labeled humanized anti-CD18 antibodies and fragments and kits comprising sameUNIV CAMBRIDGE TECH·Filed 1999·Granted Feb 10, 2004·30 cites·22 claims
- 2271US7947272B2Compositions and methods of tolerizing a primate to an antigenTOLERX INC·Filed 2006·Granted May 24, 2011·1 cites·21 claims
- 2369US2021269544A1Therapeutic antibodiesCYTOMX THERAPECUTICS INC·Filed 2020·Application pending·0 cites
- 2467US6767996B1Altered antibodies and their preparationGLAXO WELLCOME INC·Filed 1991·Granted Jul 27, 2004·17 cites·11 claims
- 2560US10800850B2Therapeutic antibodiesCYTOMX THERAPEUTICS INC·Filed 2015·Granted Oct 13, 2020·0 cites·17 claims
- 2660US2014212418A1Therapeutic AntibodiesWALDMANN HERMAN·Filed 2013·Application pending·0 cites
- 2759US2007212753A1Altered antibodies and their preparationBURROUGHS WELLCOME CO·Filed 2005·Application pending·0 cites
- 2858US2002131962A1Method of producing dendritic cellsISIS INNOVATION·Filed 2002·Application pending·0 cites
- 2956US7541443B2Anti-CD4 antibodiesTOLERRX INC·Filed 2003·Granted Jun 2, 2009·0 cites·13 claims
- 3053US2011282037A1Antibody preparationWALDMANN HERMAN·Filed 2011·Application pending·0 cites
- 3152US2024124551A1Methods and compositions for cellular therapyREPLAY HOLDINGS INC·Filed 2023·Application pending·0 cites
- 3251US2005118172A1CDw52-specific antibody for treatment of multiple sclerosisFiled 2004·Application pending·0 cites
- 3350US7098006B1Chimeric antibody, pharmaceutical composition and process of its productionBURROUGHS WELLCOME CO·Filed 1995·Granted Aug 29, 2006·6 cites·12 claims
- 3449US2002131968A1Antibody preparationFiled 2000·Application pending·0 cites
- 3549US2025270283A1Methods and compositions for cellular therapyREPLAY HOLDINGS INC·Filed 2023·Application pending·0 cites
- 3649US2004109855A1Therapeutic antibodies with reduced side effectFiled 2003·Application pending·0 cites
- 3745US2013028893A1Therapeutic antibodies with reduced side effectWALDMANN HERMAN·Filed 2011·Application pending·0 cites
- 3844US2011008330A1Compositions and methods of tolerizing a primate to an antigenFREWIN MARK·Filed 2010·Application pending·0 cites
- 3943US2003108518A1TRX1 antibody and uses thereforFiled 2002·Application pending·0 cites
- 4041US2005037004A1Treatment of chronic joint inflammationISIS INNOVATION·Filed 2002·Application pending·0 cites
- 4140US10906976B2Induction of immunotolerance to improve acceptance of tissue derived from pluripotent stem cellsUNIV HONG KONG CHINESE·Filed 2016·Granted Feb 2, 2021·0 cites·16 claims
- 4236US2012282184A1Treatment of obesityWALDMANN HERMAN·Filed 2010·Application pending·0 cites
- 4334USRE46877EAltered antibodies and their preparationBTG INT LTD·Filed 1991·Granted May 29, 2018·2 cites·18 claims
- 4431US4841025AAntibody preparationsNAT RES DEV·Filed 1988·Granted Jun 20, 1989·2 cites·15 claims
- 4529US5670150ANon-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM)UNIV LONDON·Filed 1995·Granted Sep 23, 1997·2 cites·9 claims
- 4627US2002048578A1Antibody variantsFiled 1997·Application pending·0 cites
- 4726USRE43898EAltered antibodies and their preparationGLAXO WELLCOME INC RES·Filed 1991·Granted Jan 1, 2013·1 cites·19 claims
- 4824US5786176ARecombinant CDw52 antigenBRITISH TECH GROUP·Filed 1993·Granted Jul 28, 1998·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Herman Waldmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →